Bearing Point Capital, LLC Gilead Sciences, Inc. Transaction History

Bearing Point Capital, LLC

  • $581 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$96.91 - $113.0 $200,797 - $234,136
-2,072 Reduced 48.19%
2,228 $247 Million
Q1 2025

May 07, 2025
SELL
$89.14 - $117.41 $184,519 - $243,038
-2,070 Reduced 32.5%
4,300 $482 Million
Q4 2024

Feb 14, 2025
BUY
$83.95 - $97.9 $534,761 - $623,623
6,370 New
6,370 $588 Million

Others Institutions Holding GILD

# of Institutions
2,386
Shares Held
1.01B
Call Options Held
8.58M
Put Options Held
7.35M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bearing Point Capital, LLC Portfolio

Follow Bearing Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bearing Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bearing Point Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email